emcure pharma ipo lists at 30% premium | namita thapar & satish mehta share details | business news
Published 3 weeks ago • 1.8K plays • Length 6:46Download video MP4
Download video MP3
Similar videos
-
0:43
namita thapar's emcure pharma makes bumper #stockmarket debut, lists at 31% premium on nse
-
0:48
namita thapar's emcure pharma ipo opens: should you bid? | ipo #shorts
-
0:53
emcure pharma ipo listing: shares debut at nearly 32% premium over ipo price | n18s | cnbc tv18
-
0:59
namita thapar to gain ₹127.8 cr from emcure pharma ipo
-
39:25
live: namita thapar-backed emcure pharma ipo to debut on the bourses | ipo listing | n18l |cnbc tv18
-
5:08
emcure pharma ipo: namita thappar on tie up with sanofi & in-house products for cardiac segment
-
1:31
strong debut for emcure pharma: lists at 31% premium
-
22:23
budget 2024 | semiconductor stocks | pli schemes | ca rachana ranade
-
1:33
emcure pharmaceuticals ipo: satish mehta expands on biotech brands and upcoming products
-
3:00
emcure pharma ipo launches today; everything you need to know about the pharma company
-
0:59
emcure pharma lists at 31% premium over ipo price, management to focus on emerging markets
-
7:44
emcure pharma ipo to open next week, rationale behind the fundraise & utilization plans | et now
-
1:14
namita thapar-backed emcure pharma ipo to fetch her 127 cr on exit
-
2:19
emcure pharma makes a stellar debut, lists at 31% premium to issue price | cnbc tv18
-
19:30
will you invest in shark tank's namita thapar's company. emcure pharma ipo to open on july 3rd
-
8:41
emcure pharma ipo oversubscribed; growth & expansion plans | samit mehta & vikas thapar | et now
-
3:45
emcure pharma ipo open for subscription today, all you need to know! | investors & valuation |et now
-
2:26
‘shark’ namita thapar’s investment swells 38,200% after strong emcure pharma listing! | details
-
4:06
emcure pharma ipo: all you need to know before investing
-
25:46
namita thapar-backed emcure pharma’s rs 1,952 cr ipo opens|management on post-ipo roadmap| ipo watch
-
0:21
namita thapar's emcure pharma lists at 31% premium on nse
-
5:44
emcure pharma ipo launch: what to expect? market expert sneha poddar analysis the ipo debut